1. Home
  2. SCYX vs GWH Comparison

SCYX vs GWH Comparison

Compare SCYX & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • GWH
  • Stock Information
  • Founded
  • SCYX 1999
  • GWH 2011
  • Country
  • SCYX United States
  • GWH United States
  • Employees
  • SCYX N/A
  • GWH N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • SCYX Health Care
  • GWH Miscellaneous
  • Exchange
  • SCYX Nasdaq
  • GWH Nasdaq
  • Market Cap
  • SCYX 50.3M
  • GWH 56.8M
  • IPO Year
  • SCYX 2014
  • GWH N/A
  • Fundamental
  • Price
  • SCYX $0.99
  • GWH $5.07
  • Analyst Decision
  • SCYX Buy
  • GWH Buy
  • Analyst Count
  • SCYX 1
  • GWH 6
  • Target Price
  • SCYX N/A
  • GWH $2.54
  • AVG Volume (30 Days)
  • SCYX 212.6K
  • GWH 82.3K
  • Earning Date
  • SCYX 11-06-2024
  • GWH 11-13-2024
  • Dividend Yield
  • SCYX N/A
  • GWH N/A
  • EPS Growth
  • SCYX N/A
  • GWH N/A
  • EPS
  • SCYX N/A
  • GWH N/A
  • Revenue
  • SCYX $8,566,000.00
  • GWH $6,241,000.00
  • Revenue This Year
  • SCYX N/A
  • GWH $32.11
  • Revenue Next Year
  • SCYX $405.82
  • GWH $341.09
  • P/E Ratio
  • SCYX N/A
  • GWH N/A
  • Revenue Growth
  • SCYX N/A
  • GWH 31.11
  • 52 Week Low
  • SCYX $0.90
  • GWH $4.35
  • 52 Week High
  • SCYX $3.07
  • GWH $18.00
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 30.44
  • GWH 41.97
  • Support Level
  • SCYX $0.90
  • GWH $4.35
  • Resistance Level
  • SCYX $1.25
  • GWH $5.30
  • Average True Range (ATR)
  • SCYX 0.08
  • GWH 0.46
  • MACD
  • SCYX -0.01
  • GWH 0.01
  • Stochastic Oscillator
  • SCYX 23.54
  • GWH 42.11

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: